Kopran Limited (KOPRAN.BO) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close250.40

Open254.95

Day range251.15267.15

52-week range107.00295.90

Off day high−0.84%

Off 52-week high−10.48%

Volume40.25K

Avg. volume (3M)66.42K

Market cap12.80B

EPS (TTM)5.17

Forward P/E39.72

P/E ratio (TTM)51.24

Dividend yield1.25% (3.00)

Beta (5Y)1.01

Shares outstanding48.33M

Short interest—

Earnings dateAug 6, 2025 (est.)

Analyst target—

Profit margin3.57%

Against its peers

Compare in full ›

	KOPRAN.BO	014570.KQ	002422.SZ	KLBF.JK	THEMISMED.NS	KILITCH.NS
Market cap	12.80B	30.31B	71.95B	34.35T	9.44B	7.29B
P/E (TTM)	51.2	—	36.5	9.1	23.5	23.7
Forward P/E	39.7	—	30.2	10.2	—	13.6
Price/book	2.4	—	2.8	1.4	2.4	2.6
Dividend yield	1.25%	6.41%	1.37%	2.76%	0.50%	—
1-year change	+56.40%	−35.25%	+28.94%	−42.00%	−15.87%	+10.83%
Today	+5.79%	−0.36%	+4.02%	+4.83%	+2.13%	−0.21%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Kopran's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Korean Drug Co., Ltd.014570.KQ · Drug Manufacturers - General	30.31B	2,800.00	−0.36%
Sichuan Kelun Pharmaceutical Co., Ltd.002422.SZ · Drug Manufacturers - General	71.95B	45.23	+4.02%
PT Kalbe Farma Tbk.KLBF.JK · Drug Manufacturers - General	34.35T	760.00	+4.83%
Themis Medicare LimitedTHEMISMED.NS · Drug Manufacturers - Specialty & Generic	9.44B	101.64	+2.13%
Kilitch Drugs (India) LimitedKILITCH.NS · Drug Manufacturers - Specialty & Generic	7.29B	208.47	−0.21%
KPC Pharmaceuticals,Inc.600422.SS · Drug Manufacturers - Specialty & Generic	6.71B	8.86	+1.61%
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.603707.SS · Drug Manufacturers - Specialty & Generic	14.07B	8.71	+7.53%
Kukje Pharma Co., Ltd.002720.KS · Drug Manufacturers - Specialty & Generic	70.36B	3,325.00	−1.63%

Other companies in Drug Manufacturers - General, closest in size first.

Company	Mkt cap	Price	Today
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.300357.SZ · Huzhou, China	12.04B	22.99	+2.73%
Yifan Pharmaceutical Co., Ltd.002019.SZ · Hangzhou, China	11.87B	9.76	+2.41%
Recordati Industria Chimica e Farmaceutica S.p.A.REC.MI · Milan, MI	11.02B	53.00	−0.19%
Chongqing Lummy Pharmaceutical Co., Ltd.300006.SZ · Chongqing, China	10.81B	10.24	+7.45%
CSPC Pharmaceutical Group LimitedCVG.F · Shijiazhuang, China	10.81B	0.9478	+3.60%
Orion OyjOFK.F · Espo, Finland	14.28B	101.70	+2.99%
CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.000908.SZ · Changde, China	9.68B	5.50	0.00%
Zhejiang Jolly Pharmaceutical Co.,LTD300181.SZ · Huzhou, China	8.83B	12.59	+0.16%

Healthcare companies of a similar market value (11.56B).

Company	Mkt cap	Price	Today
Fresenius Medical Care AGFMS · Medical Care Facilities	12.04B	23.19	+6.72%
The Cooper Companies, Inc.COO · Medical Instruments & Supplies Odds	12.25B	64.42	+5.90%
Ping An Healthcare and Technology Company Limited1833.HK · Health Information Services	12.74B	5.990	+7.54%
MicroPort Scientific Corporation0853.HK · Medical Devices	11.62B	6.075	0.00%
LBX Pharmacy Chain Joint Stock Company603883.SS · Pharmaceutical Retailers	11.45B	14.94	+1.36%
DaVita Inc.DVA · Medical Care Facilities	12.12B	192.66	+5.76%
Vikram Thermo (India) LimitedVIKRAMTH.BO · Drug Manufacturers - Specialty & Generic	10.41B	332.00	−2.51%
Nahdi Medical Company4164.SR · Pharmaceutical Retailers	12.09B	93.00	+2.54%

Also based in Mumbai, India, then elsewhere in India.

Company	Mkt cap	Price	Today
ICICI Bank LimitedIBN.BA · Mumbai, India	188.59T	52,525.00	+4.48%
Reliance Industries LimitedRELIANCE.BO · Mumbai, India	17.78T	1,313.35	+0.08%
HDFC Bank LimitedHDFCBANK.NS · Mumbai, India	11.73T	760.00	+3.16%
State Bank of IndiaSBIN.NS · Mumbai, India	9.29T	1,006.40	+2.80%
Tata Consultancy Services LimitedTCS.BO · Mumbai, India	9.02T	2,493.00	+2.38%
Larsen & Toubro LimitedLT.BO · Mumbai, India	5.56T	4,042.10	+2.69%
Life Insurance Corporation of IndiaLICI.NS · Mumbai, India	5.16T	408.00	0.00%
Kotak Mahindra Bank LimitedKOTAKBANK.NS · Mumbai, India	4.65T	467.00	+1.65%

Companies that serve the same markets: life sciences, devices.

Company	Mkt cap	Price	Today
Daiichi Sankyo Company, LimitedD4S.F · devices · life sciences	31.06B	17.05	+5.64%
Zhejiang Jolly Pharmaceutical Co.,LTD300181.SZ · devices · life sciences	8.83B	12.59	+0.16%
Ono Pharmaceutical Co., Ltd.ON4.F · devices · life sciences	6.28B	13.37	+4.90%
Kilitch Drugs (India) LimitedKILITCH.NS · devices · life sciences	7.29B	208.47	−0.21%
Medicamen Biotech LimitedMEDICAMEQ.BO · devices · life sciences	3.69B	262.40	−0.57%
Coral Laboratories LimitedCORALAB.BO · devices · life sciences	1.77B	494.85	+1.78%
Bal Pharma LimitedBALPHARMA.BO · devices · life sciences	1.30B	81.80	−0.24%
Vista Pharmaceuticals LimitedVISTAPH.BO · devices · life sciences	391.47M	6.36	+2.75%

What visitors to Kopran's page also look at.

Company	Mkt cap	Price	Today
MARKSANS PHARMA LTD.MARKSANS.BO	142.25B	313.65	+4.15%
MOREPEN LABORATORIES LTD.MOREPENLAB.BO	53.04B	96.80	−3.44%
SMS PHARMACEUTICALS LTD.SMSPHARMA.BO	48.32B	515.95	−1.99%
NECTAR LIFESCIENCES LTD.NECLIFE.BO	1.97B	10.15	−1.65%
SUVEN LIFE SCIENCES LTD.SUVEN.BO	63.96B	275.75	−0.14%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All KOPRAN.BO news ›

Multibagg AI·21h ago

Kopran Limited reports 58% of HY27 formulations sales in South Africa

Kopran reported Rs 81.77 crore of HY 2026-27 formulations sales from South Africa, nearly 58% of its Rs 141.31 crore total, while the Pen Plant contributed Rs 78.14 crore, or about 55%. The half-year data therefore shows concentration in…

SAHI·1d agoPositive

Kopran Posts Q2 Consolidated Net Profit of ₹4.4 Crore vs ₹10 Crore Loss YoY

Market snapshot: Kopran Limited reported a consolidated net profit of ₹4.4 crore for the second quarter ending September 30, 2026. This performance marks an operational turnaround from a consolidated net loss of ₹10 crore recorded in the…

EquityBulls·Oct 22Positive

Medicine Authority European Union conducts GMP inspection at Kopran's Khopoli Facility

22 Oct 2026, 04:05 PM IST Equity Bulls Stock Report Kopran Limited INE082A01010 Medicine Authority European Union (EU) - conducted GMP inspection at the Company’s Formulation, manufacturing facility located at Khopoli, from September 18,…

SAHI·Oct 22Positive

Kopran Reports Successful Inspection Of Khopoli Facility With No Major Concerns

Kopran Limited disclosed that its key manufacturing unit at Khopoli underwent an inspection with zero major regulatory concerns reported (as stated in the source alert; not independently verified). The clearance provides operational…

KGEI

From the 4Search news index, newest first.

In the news

4mentions in 30 days

4with it in the headline

Positivesentiment

Most coverage from

sahi.com2
equitybulls.com1
multibagg.ai1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.